Online Program

335574
One disparate mission: Health care access according to The BRICS


Tuesday, November 3, 2015 : 5:30 p.m. - 5:45 p.m.

Paul Kadetz, PhD, MPH, MSN, Department of Public Health, Marshall University, Huntington, WV
The unification of Brazil, Russia, India, China and South Africa as a political economic grouping, known as The BRICS, has been assumed to offer an alternative “south-south” development for low-income countries. Among areas of joint concern, health care access has become a focal mission since the first meeting of BRICS health ministers in 2011 and documented in their joint mission statement of health diplomacy; The Beijing Declaration. However, do The BRICS domestically practice or even frame health care access in the same manner? This systematic review compares how each of The BRICS has attempted to achieve health care access, both domestically and in their foreign aid directed to the health sector. Marked differences are identified in how each country prioritizes and attempts to achieve health care access, particularly in overcoming growing gaps of per capita income inequalities. This research problematizes the ability of The BRICS to achieve consensus on how to prioritize or foster health care access in their joint health diplomacy and health advocacy.

Learning Areas:

Advocacy for health and health education
Diversity and culture
Public health or related public policy
Social and behavioral sciences

Learning Objectives:
Differentiate between how the BRICS nations understand health care access. Identify the difference between political discourse and interventions in the BRICS health aid representations.

Keyword(s): International Health, Accessibility

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I conducted and analyzed the research presented.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4427.0: Advocacy in Global Health